LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
LUCY
Innovative Eyewear, Inc.
There isn't enough reported data to score LUCY yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
LUCY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
LUCY's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
LUCY PE Valuation
LUCY has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
LUCY Forward outlook
There aren't enough analyst estimates for LUCY to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over LUCY on earnings quality, reporting a profit while its opponent remains loss making.
LUCY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.04 | +$2.90 |
| Q2 2026 | -$1.15 | +$3.40 |
| Q1 2026 | -$1.55 | +$4.21 |
| Q4 2025 | -$1.90 | +$6.14 |
| Q3 2025 | -$3.94 | +$5.72 |
| Q2 2025 | -$4.55 | +$6.52 |
| Q1 2025 | -$5.76 | +$6.44 |
| Q4 2024 | -$8.04 | +$4.56 |
LUCY is still losing money, but far less than before: $1.04 per share over the past year, against $15.84 at its worst in mid-2022.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
LUCY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1M | +51% |
| Q2 2026 | $1M | +74% |
| Q1 2026 | $773.6K | +70% |
| Q4 2025 | $959.8K | +39% |
| Q3 2025 | $668.1K | +163% |
| Q2 2025 | $579.2K | +88% |
| Q1 2025 | $454.5K | +19% |
| Q4 2024 | $690.7K | +12% |
LUCY has the edge over LLY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | -503% | -319 points |
| Q4 2021 | -501% | +393 points |
| Q3 2021 | -638% | +452 points |
| Q2 2021 | -408% | +1115 points |
| Q1 2021 | -185% | +1338 points |
| Q4 2020 | -894% | N/A |
| Q3 2020 | -1090% | N/A |
| Q2 2020 | -1523% | N/A |
LUCY's operating margin was −503% last quarter, down 319 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with LUCY at down 74%.
LUCY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.4M | +$602.4K |
| Q3 2025 | -$1.5M | -$112.6K |
| Q2 2025 | -$2.1M | -$183.7K |
| Q1 2025 | -$2.4M | -$852K |
| Q4 2024 | -$2M | -$860K |
| Q3 2024 | -$1.4M | +$30K |
| Q2 2024 | -$1.9M | -$82.6K |
| Q1 2024 | -$1.5M | -$44.4K |
LUCY has burned cash in almost every quarter: −$7M over the past year, against −$7M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over LUCY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
LUCY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +31% | +2M shares |
| 1 year | +162% | +5.2M shares |
| 3 years | +1900% | +8M shares |
| 5 years | +3769% | +8.2M shares |
| Available history | +8365% | +8.3M shares |
LUCY has 8M diluted shares, up 162% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
LUCY Net Leverage
LUCY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
LUCY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 24.7 | Neutral |
LUCY's weekly RSI is 44 (neutral) and its Stochastic is 25 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
LUCY PE vs Healthcare Sector
LUCY has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over LUCY on trend strength, trading above more of its moving averages.
LUCY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.86 | 5.8% below |
| 20 week MA | $0.83 | 2.4% below |
| 50 week MA | $1.01 | 20% below |
| 100 week MA | $1.96 | 59% below |
| 200 week MA | $8.99 | 91% below |
LUCY is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over LUCY on returns for 2026, with the stronger performance.
LUCY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $96.0 | $15.5 | -84% |
| 2023 | $15.5 | $8.44 | -46% |
| 2024 | $8.44 | $5.02 | -41% |
| 2025 | $5.02 | $1.22 | -76% |
| 2026 YTD | $1.22 | $0.81 | -34% |
LUCY has finished every year since 2022 lower, and it's down 34% so far in 2026.